Physician profile
Charles Wayne Plummer
NPI 1285709691
$2,060.27
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,072 · 2020: $528 · 2021: $422 · 2022: $37.95.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $492.50 | 2019-2021 | |
| Daiichi Sankyo INC. | $330.22 | 2019 | |
| Collegium Pharmaceutical, INC. | $242.61 | 2019-2021 | |
| Indivior INC. | $211.96 | 2019-2021 | |
| Redhill Biopharma INC. | $166.97 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $143.28 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $131.78 | 2019-2021 | |
| Orexo US, INC. | $107.44 | 2019-2022 | |
| Pfizer INC. | $79.56 | 2019-2021 | |
| Uswm, LLC | $43.85 | 2021 | |
| Pacira Therapeutics, INC. | $40.84 | 2019 | |
| Mdd US Operations, LLC | $26.91 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $24.16 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.19 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Plummer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.